PHILADELPHIA, May 30, 2006 – Hahnemann University Hospital is proud to announce its oncology program has received a full, Three-Year with Commendation approval from the Commission on Cancer of the American College of Surgeons (ACoS).

Established in 1922, the Commission on Cancer’s Approvals Program sets quality-of-care standards for cancer facilities ensuring these institutions conform to ACoS regulations in providing oncology patients a high level of quality cancer care.

“We are tremendously proud our oncology program has earned this national recognition,” said Michael P. Halter, president and CEO, Hahnemann University Hospital. “As only one in four hospitals that treat cancer receive this credential, the recognition serves as a true testament to the dedication and commitment of Hahnemann University Hospital’s oncology physicians, nurses and staff members in providing patients and their families with the highest level of quality cancer treatment and care.”

As a Commission on Cancer approved program, Hahnemann University Hospital oncology patients have access to:
· Quality care close to home
· Comprehensive care offering a range of sophisticated services and equipment
· A multi-specialty, team approach to coordinate treatment options
· Information about cancer clinical trials, education and support
· Lifelong patient follow-up through a cancer registry that collects data on the type and stage of cancers   along with treatment results
· Ongoing monitoring and improvement of care

For more information about the Commission on Cancer, please visit www.facs.org/cancer/index.html.